Cove Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$702K Hold
11,575
0.16% 104
2025
Q4
$624K Sell
11,575
-695
-6% -$33.4K 0.19% 97
2025
Q3
$553K Sell
12,270
-1,095
-8% -$51.1K 0.18% 99
2025
Q2
$619K Buy
13,365
+2,020
+18% +$99.2K 0.22% 91
2025
Q1
$692K Buy
11,345
+2,350
+26% +$137K 0.36% 69
2024
Q4
$509K Hold
8,995
0.31% 68
2024
Q3
$465K Sell
8,995
-1,175
-12% -$55.1K 0.36% 59
2024
Q2
$422K Hold
10,170
0.34% 61
2024
Q1
$552K Hold
10,170
0.47% 53
2023
Q4
$522K Buy
+10,170
New +$534K 0.49% 53

Other funds holding BMY

Cove Private Wealth's BMY Position: Q1 2026 in Review

Cove Private Wealth held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 11,575 shares worth $702K. The position accounts for 0.16% of the portfolio, ranked #104.

Cove Private Wealth first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cove Private Wealth held 11,575 shares of Bristol-Myers Squibb worth $702K as of Q1 2026.
  • Cove Private Wealth left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.16% of Cove Private Wealth's portfolio in Q1 2026, its #104 holding.
  • Cove Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cove Private Wealth's 13F filing for Q1 2026, filed 14 May 2026.